Heart Failure Medical Management in 2020: Searching for the Right Polypharmacy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Characteristics, management, and predictors of 6-month mortality in very elderly patients admitted for decompensated heart failure.Journal of geriatric cardiology : JGC · 2025
   Article
2. Iron therapy for patients with iron deficiency and heart failure: a treatment strategy that is increasingly opaque.Proceedings (Baylor University. Medical Center) · 2024
   Article
3. Prioritizing geriatrics in medical education improves care for all.Medical education online · 2022
   Article
4. Clinical Perspectives on Cardiac Rehabilitation After Heart Failure in Elderly Patients with Frailty: A Narrative Review.Therapeutics and clinical risk management · 2022
   Review

Corrections and comments

• Comment on
  Polypharmacy in Older Adults Hospitalized for Heart Failure.2020

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as